• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
LMK-235

LMK-235

Product ID L493400
Cas No. 1418033-25-6
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $95.30 In stock
25 mg $408.80 In stock
100 mg $1,044.80 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

LMK-235 is an HDAC inhibitor, selectively targeting HDAC4 and HDAC5. It induces apoptosis in multiple myeloma cells, a cancer type with a high rate of relapse. This activity is attributed to the downregulation of heme oxygenase-1 (HO-1), which is closely related to HDAC4, as well as increased phosphorylation of JNK.

Product Info

Cas No.

1418033-25-6

Purity

≥98%

Formula

C15H22N2O4

Formula Wt.

294.35

IUPAC Name

N-{[6-(Hydroxyamino)-6-oxohexyl]oxy}-3,5-dimethylbenzamide

Synonym

LMK235

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

L493400 MSDS PDF

Info Sheet

L493400 Info Sheet PDF

References

Marek L., Hamacher A., et al. Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. J Med Chem. 56(2):427-36 (2013). PMID: 23252603.

Li X., Guo Y., et al. Histone deacetylase inhibitor LMK-235-mediated HO-1 expression induces apoptosis in multiple myeloma cells via the JNK/AP-1 signaling pathway. Life Sci. 223:146-157 (2019). PMID: 30876940.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • I0010

    5-(9-Isopropyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine

    Intermediate in the synthesis of purine analogs...

    ≥98%
  • S8144

    Sulfadoxine

    Sulfonamide; dihydropteroate synthase inhibitor...

    ≥98%
  • C1633

    Cefotaxime Sodium

    β-lactam cephalosporin; penicillin binding pro...

    ≥96%
  • I7659

    1-Isothiocyanato-8-(methylsulfonyl)-octane

    ITC, erysolin analog.

    ≥98%
  • D0032

    Daidzein

    Phytoestrogen, isoflavone found in various plan...

    ≥97%
  • D1995

    Dexrazoxane Hydrochloride

    Iron chelator.

    ≥98%
  • C2969

    Chromomycin A3

    Anthraquinone, Mg2+/Zn2+ chelator; bacterial DN...

    ≥97%
  • L930280

    LXH254

    pan-RAF inhibitor

    ≥99%
  • N0069

    Naringin

    Flavanone glycoside found in citrus fruit; SERM...

    ≥97%
  • S584780

    Sotorasib racemate

    KRAS inhibitor

    ≥99%
  • N8604

    NVP-BGT226

    PI3K and mTOR inhibitor.

    ≥98%
  • S0253

    Sanguinarine

    Benzophenanthridine alkaloid found in various p...

    ≥98%
  • L9602

    LY-2874455

    FGFR inhibitor.

    ≥98%
  • O5212

    Ondansetron Hydrochloride Dihydrate

    5-HT3 antagonist.

    ≥98%
  • L1682

    Levamisole Hydrochloride

    Imidazothiazole; alkaline phosphatase inhibitor...

    ≥98%
  • G8800

    GW-788388

    ALK5 (activin-like) antagonist.  
    ≥97%
  • M568266

    Mogroside IIIe

    Triterpenoid

    ≥98%
  • G2869

    Ghrelin, rat

    Endogenous peptide hormone, involved in feeding...

    ≥95%
  • C600000

    CP 55940

    Non-selective CB receptor agonist.  
    ≥97%
  • P3348

    Pimecrolimus

    Calcineurin inhibitor, potential TRPV1 agonist....

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only